Kinase Inhibitors in Genetic Diseases
Over the years, several studies have shown that kinase-regulated signaling pathways are involved in the development of rare genetic diseases. The study of the mechanisms underlying the onset of these diseases has opened a possible way for the development of targeted therapies using particular kinase...
Main Authors: | Lucia D’Antona, Rosario Amato, Carolina Brescia, Valentina Rocca, Emma Colao, Rodolfo Iuliano, Bonnie L. Blazer-Yost, Nicola Perrotti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/6/5276 |
Similar Items
-
Redesigning TOR Kinase to Explore the Structural Basis for TORC1 and TORC2 Assembly
by: Andrew Hill, et al.
Published: (2018-06-01) -
Construction of a ceRNA Network Related to Rheumatoid Arthritis
by: Zhanya Huang, et al.
Published: (2022-04-01) -
Pathway-Directed Therapy in Multiple Myeloma
by: Lukas John, et al.
Published: (2021-04-01) -
Propofol suppresses growth, migration and invasion of A549 cells by down-regulation of miR-372
by: Hai Sun, et al.
Published: (2018-12-01) -
Clinical Implications of mTOR Expression in Papillary Thyroid Cancer—A Systematic Review
by: Aleksandra Derwich, et al.
Published: (2023-03-01)